Atlas Trials

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Clinical trial NCT01015248 · COMPLETED

Trial details

NCT number
NCT01015248
Sponsor
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MALT LYMPHOMA
Start date
2009-05-01
Primary completion
2013-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.